Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 24, 2005
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical productsJérôme Bouligand, Thomas Storme, Isabelle Laville, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Ultrasonics|January 15, 2008
Acoustic characterization of a new trisacryl contrast agent. Part I: In vitro studySonia Lavisse, Valerie Rouffiac, Pierre Peronneau, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinomaChristophe Maritaz, David Combarel, Cécile Dalban, et al.
European Journal of Cancer (Oxford, England : 1990)|February 11, 2020
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodiesAude Desnoyer, Sophie Broutin, Julia Delahousse, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxicsAngelo Paci, Gareth Veal, Christophe Bardin, et al.
Pharmacology & Therapeutics|March 5, 2019
Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severityAli N Chamseddine, Michel Ducreux, Jean-Pierre Armand, et al.
Ultrasonics|January 15, 2008
Acoustic characterization of a new trisacryl contrast agent. Part II: Flow phantom study and in vivo quantificationSonia Lavisse, Pierre Peronneau, Valerie Rouffiac, et al.
Pageof 11